Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | POLB | P06746 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | GFER | P55789 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14734389 | 0.83 | KDM4E (0.38) | KDM4EPOLBMAPTL3MBTL1TDP1 | |
| SCHEMBL14734431 | 0.77 | KDM4E (0.38) | KDM4EPOLBMAPTL3MBTL1TDP1 | |
| SCHEMBL2168269 | 0.77 | CA12 (0.42) | KDM4EMAPTL3MBTL1TDP1SMN1; SMN2 | |
| SCHEMBL3860724 | 0.75 | KDM4E (0.39) | KDM4EPOLBMAPTL3MBTL1TDP1 | |
| SCHEMBL30681950 | 0.75 | TDP1 (0.38) | KDM4EPOLBMAPTL3MBTL1TDP1 | |
| Water SCHEMBL28571228 | 0.74 | CA12 (0.41) | KDM4EMAPTL3MBTL1TDP1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL11596190 | 0.74 | CA12 (0.41) | KDM4EMAPTL3MBTL1TDP1SMN1; SMN2 | |
| SCHEMBL2539130 | 0.74 | NPC1 (0.52) | KDM4EPOLBMAPTL3MBTL1TDP1 | |
| SCHEMBL2406851 | 0.73 | POLB (0.36) | KDM4EPOLBMAPTL3MBTL1TDP1 | |
| SCHEMBL9621309 | 0.73 | NPC1 (0.43) | KDM4EPOLBMAPTL3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050004130-A1 | New metabotropic glutamate receptor compounds | ASTRAZENECA AND NPS PHARMACEUTICALS, INC. | 2005-01-06 | — | — | US | claimed |
| EP-1587796-A1 | SATURATED QUINOXALINE DERIVATIVES AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR LIGANDS | AstraZeneca AB (SE) | 2005-10-26 | — | — | EP | disclosed |
| US-20050004130-A1 | New metabotropic glutamate receptor compounds | ASTRAZENECA AND NPS PHARMACEUTICALS, INC. | 2005-01-06 | — | — | US | disclosed |
| WO-2004069813-A1 | SATURATED QUINOXALINE DERIVATIVES AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR LIGANDS | ASTRAZENECA AB (SE) | 2004-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050004130-A1 | New metabotropic glutamate receptor compounds | GRM1, GRIN1, GRM2 | KDM4E 3065/4885POLB 3426/4885MAPT 1438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.